Benchling

Benchling

Benchling is a company based in San Francisco focusing on life science collaboration, both private and public, through creating cloud based software tools for digital DNA sequence editing, designing and running experiments, analyzing data, and sharing research.

Benchling is based in San Fransisco and was founded in 2012 by Sajith Wickramasekara, Ashutosh Singhal and Cory Li of MIT. The company focuses on life science collaboration, both private and public, through creating cloud based software tools for digital DNA sequence editing, designing and running experiments, analyzing data, and sharing research.

Products and services

Electronic lab notebook

Benchling software includes an electronic lab notebook that allows researchers to document their experiments. Benchling claims their notebook software reduces data entry time by up to 85%.

Molecular biology suite

The molecular biology suite is an integrated, all in one, interface offering CRISPR guides, automation of primer designs, plasmid visualization, sequence alignment, and other relevant biological and chemical software tools.

Bioregistry

The bioregistry is a fully integrated platform for creating, organizing, and documenting workflow for biologists, particularly for sequence editing and strain engineering. Benchling designed the bioregistry to track and assign features to organisms, import data from standardized databases, and give biologists the power to take notes within the bioregistry itself.

Sample tracking

Bechling offers an inventory tracking system with their software. The system allows for the tracking of individual samples, containers, and instruments within the lab.

Workflow management

Benchling offers a workflow management systems that helps to design and manage work, provide feedback on progress, identify workflow bottlenecks, and improve decision making.

Funding

Angel round

On December 1, 2012 Benchling became the first synthetic biology company to be backed by Y Combinator and received $900,000 in funding from: Y Combinator, FF Angel, Draper Associates, and other angel investors.

Seed

On April 15, 2015 Benchling raised $5,000,000 in seed funding from Andreessen Horowitz, Thrive Capital, and Kevin Mahaffey. The funding helped Benchling grow their software engineering and customer support teams.

Series A

On October 3, 2016 Benchling completed their series A funding round, raising $7,000,000 from Thrive Capital.

Partnerships

Gen9

On November 16, 2016 Benchling announced its partnership with Gen9 — a company making making synthetic DNA. The partnerships between the two companies seeks to make it easier for customers to order large DNA libraries from Gen9 using Benchling's online software.

Timeline

July 24, 2019

Benchling's software for managing biotech research raises series B of $34.5 million

July 2019

Benchling raises a $34,500,000 series C round from Thrive Capital, Menlo Ventures, Y Combinator, Benchmark and Lead Edge Capital.

June 2018

Benchling raises a $14,500,000 series B round from Thrive Capital, F-Prime Capital Partners and Benchmark.

November 16, 2016

Partnership: Gen9

On November 16, 2016 Benchling announced its partnership with Gen9 — a company making making synthetic DNA. The partnerships between the two companies seeks to make it easier for customers to order large DNA libraries from Gen9 using Benchlings online software.

October 3, 2016

Series A funding round

On October 3, 2016 Benchling completed their series A funding round, raising $7,000,000 from Thrive Capital.

April 15, 2015

Seed funding

​On April 15, 2015 Benchling raised $5,000,000 in seed funding from Andreessen Horowitz, Thrive Capital, and Kevin Mahaffey. The funding helped Benchling grow their software engineering and customer support teams.

December 1, 2012

Angel round funding

On December 1, 2012 Benchling became the first synthetic biology company to be backed by Y Combinator and received $900,000 in funding from: Y Combinator, FF Angel, Draper Associates, and other angel investors.

May 22, 2012

Benchling was founded by Ashutosh Singhal, Sajith Wickramasekara and Cory Li.

People

Name
Role
LinkedIn

Adam Draper

Investor

Andrey Ivanov

Employee

Ashutosh Singhal

Augie Rakow

Attorney

Christopher Golda

Investor

David Wallerstein

Investor

Emoke Starr

Employee

Farbod Forouzin

Employee

Geoff Ralston

Investor

Hannah Shen

Employee

Henry Holbrook

Employee

Jeff Schox

Attorney

Joshua Ma

Employee

Jude Gomila

Investor

Kenneth B Hertz

Investor

Kevin Mahaffey

Investor

Lauren Chircus

Employee

Lauren Shields

Employee

Matt Huang

Investor

meekalbajaj

Employee

SHOW MORE (39)

Further reading

Title
Author
Link
Type
Date

Benchling Partners With Gen9 on DNA Library Design Tool as Software Suite Grows

Andrew Han

Benchling wants to become the Salesforce of biotech

Laura Lorenzetti

Google Docs for life sciences startup Benchling raises $7 million in growth funding from Thrive Capital

Sarah Buhr

The Boston University Center of Synthetic Biology (CoSBi) ICE Repository

Stephanie Paige, Sonya Iverson, Aaron Heuckroth, Swati Carr, Traci Haddock, Douglas Densmore

Academic paper

Documentaries, videos and podcasts

Title
Date
Link

Benchling Review: Best Biotech Genome Research Software - AngelKings.com

July 3, 2015

Companies

Company
CEO
Location
Products/Services
+ Add new row

News

Title
Author
Date
Publisher
Description
Jonathan Shieber
July 24, 2019
TechCrunch
In a field where the laboratory notebook is still considered the state of the art, it's no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab $34.5 million. Considering how much detailed technical work goes into the research that produces all of our great leaps forward in [...]

References